HONG KONG: The Chinese University of Hong Kong’s Faculty of Medicine says it is studying the use of microbiota transplantation – the transfer of faecal bacteria from a healthy to a diseased person – to treat obese patients with type 2 diabetes.
CUHK is also seeking to develop other new treatments using the process, Chan Ka-leung, dean of the faculty, said on Thursday. Chan was announcing the opening of the university’s Microbiota Transplantation and Research Centre – the first of its kind in Asia.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!